Smith & Nephew plc (LON:SN – Get Rating) has been assigned a consensus rating of "Moderate Buy" from the six research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 1,418.60 ($17.14).

Several research firms recently commented on SN. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a GBX 1,500 ($18.12) price objective on shares of Smith & Nephew in a research report on Tuesday, September 13th. JPMorgan Chase & Co. lowered their price target on shares of Smith & Nephew from GBX 1,442 ($17.42) to GBX 1,243 ($15.02) and set a "neutral" rating on the stock in a research note on Thursday, August 4th. Barclays lowered their price target on shares of Smith & Nephew from GBX 1,630 ($19.70) to GBX 1,550 ($18.73) and set an "overweight" rating on the stock in a research note on Thursday, August 4th. Credit Suisse Group lowered their price target on shares of Smith & Nephew from GBX 1,540 ($18.61) to GBX 1,400 ($16.92) and set an "outperform" rating on the stock in a research note on Thursday, August 4th. Finally, Berenberg Bank lowered their price target on shares of Smith & Nephew from GBX 1,800 ($21.75) to GBX 1,400 ($16.92) and set a "buy" rating on the stock in a research note on Thursday, September 8th.

Smith & Nephew Trading Down 0.6 %

SN opened at GBX 1,004.50 ($12.14) on Friday. The stock has a market capitalization of £8.75 billion and a P/E ratio of 2,050.00. Smith & Nephew has a 12 month low of GBX 994.80 ($12.02) and a 12 month high of GBX 1,379.60 ($16.67). The firm's fifty day simple moving average is GBX 1,075.14 and its 200 day simple moving average is GBX 1,172.99. The company has a current ratio of 1.78, a quick ratio of 0.84 and a debt-to-equity ratio of 53.62.

Smith & Nephew Cuts Dividend

Insider Transactions at Smith & Nephew

In related news, insider Erik Engstrom bought 332 shares of Smith & Nephew stock in a transaction that occurred on Tuesday, August 23rd. The stock was acquired at an average price of GBX 1,010 ($12.20) per share, with a total value of £3,353.20 ($4,051.72).

About Smith & Nephew

(Get Rating)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Featured Stories

• Can Caterpillar Claw Higher in a Falling Market?
• Is Dave & Buster's Immune to High Inflation and Lower Spending?
• Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
• Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
• MarketBeat: Week in Review 9/19 – 9/23

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.